Treatment of Primary CNS Lymphoma

NCT01960192 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma (PCNSL)

Interventions

DRUG: HD-MTX-Ara-C regimen
DRUG: FVD regimen

Sponsor

Mingzhi Zhang

Collaborators

[object Object]